Results 11 to 20 of about 18,104 (181)

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. [PDF]

PLoS ONE, 2014
This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive ...
Elisabetta De Cao, Alessia Melegaro, Rogier Klok, Maarten Postma   +3 more
doaj   +1 more source

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

The Lancet Global Health, 2021
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine ...
Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD   +16 more
doaj   +1 more source

Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis

Scientific Reports, 2021
Risk factors associated with mortality in invasive pneumococcal disease remain unclear. The present work is a meta-analysis of studies that enrolled only patients with invasive pneumococcal disease and reported on mortality.
Hao Chen, Hiromi Matsumoto, Nobuyuki Horita, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko   +5 more
doaj   +1 more source

Integrated genomic analysis of antibiotic resistance and virulence determinants in invasive strains of Streptococcus pneumoniae

Frontiers in Cellular and Infection Microbiology, 2023
IntroductionStreptococcus pneumoniae is an important human pathogen that may cause severe invasive pneumococcal diseases (IPDs) in young children and the elderly.
Lin Liu, Yanfei Wang, Yanfei Wang, Yanfei Wang, Lihong Ge, Dongping Hu, Xi Xiang, Ying Fu, Ying Fu, Jun Lu, Xi Li, Yunsong Yu, Yunsong Yu, Yunsong Yu, Yuexing Tu, Yuexing Tu, Xueqing Wu, Xueqing Wu, Xueqing Wu   +18 more
doaj   +1 more source

Burden of Invasive Pneumococcal Disease

Clinical Infectious Diseases, 2019
TO THE EDITOR—We read with interest the article by Kent et al [1]. The authors note that the burden of invasive pneumococcal disease (IPD) in UK infants aged
Slack, Mary, Vyse, Andrew, Madhava, Harish, Ellsbury, Gillian, Czudek, Carole, Reinert, Ralf-Rene, Gessner, Bradford   +6 more
openaire   +3 more sources

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +3 more sources

A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination

Human Vaccines & Immunotherapeutics, 2023
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and bacterial meningitis in children. Although pneumococcal conjugate vaccines (PCVs) are commonly available, invasive pneumococcal disease (IPD) still remains a life ...
Burcu Ceylan Cura Yayla, Tugba Bedir Demirdag, Emine Akkuzu, Nursel Kara, Hasan Tezer, Anıl Tapisiz   +5 more
doaj   +1 more source

Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam

Microbiology Spectrum, 2023
Nonpharmaceutical interventions (NPIs) implemented to contain SARS-CoV-2 have decreased invasive pneumococcal disease. Previous studies have proposed the decline is due to reduced pneumococcal transmission or suppression of respiratory viruses, but the ...
Monica Larissa Nation, Sam Manna, Hau Phuc Tran, Cattram Duong Nguyen, Le Thi Tuong Vy, Doan Y. Uyen, Tran Linh Phuong, Vo Thi Trang Dai, Belinda Daniela Ortika, Ashleigh Christina Wee-Hee, Jemima Beissbarth, Jason Hinds, Kathryn Bright, Heidi Smith-Vaughan, Thuong Vu Nguyen, Kim Mulholland, Beth Temple, Catherine Satzke   +17 more
doaj   +1 more source

Easy Diagnosis of Invasive Pneumococcal Disease

Emerging Infectious Diseases, 2011
Invasive pneumococcal disease (IPD) causes many cases of severe disease and death among children
Selva Jové, Laura, Krauel, Xavier, Pallarés Giner, Roman, Muñoz-Almagro, Carmen   +3 more
openaire   +4 more sources

Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

Brazilian Journal of Infectious Diseases, 2016
Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two ...
Carolina Regis Leite, Jailton Azevedo, Vivian Santos Galvão, Otávio Moreno-Carvalho, Joice Neves Reis, Cristiana Nascimento-Carvalho   +5 more
doaj   +1 more source